Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics
Swiss Polyphor has closed a €37M (CHF40M) private funding round to finance the development of…
April 12, 2017 - 3 minutes
Swiss Polyphor has closed a €37M (CHF40M) private funding round to finance the development of…
Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research.…
Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing…
AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College…